Compare HROW & RAMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HROW | RAMP |
|---|---|---|
| Founded | 1998 | 2018 |
| Country | United States | United States |
| Employees | 373 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.7B |
| IPO Year | N/A | 1994 |
| Metric | HROW | RAMP |
|---|---|---|
| Price | $46.15 | $37.57 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $69.86 | $35.60 |
| AVG Volume (30 Days) | 853.2K | ★ 1.2M |
| Earning Date | 05-11-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 22500.00 |
| EPS | N/A | ★ 2.24 |
| Revenue | N/A | ★ $812,940,000.00 |
| Revenue This Year | $31.62 | $11.18 |
| Revenue Next Year | $50.77 | $9.09 |
| P/E Ratio | ★ N/A | $16.76 |
| Revenue Growth | N/A | ★ 9.03 |
| 52 Week Low | $28.54 | $21.71 |
| 52 Week High | $54.98 | $37.92 |
| Indicator | HROW | RAMP |
|---|---|---|
| Relative Strength Index (RSI) | 70.69 | 64.45 |
| Support Level | $44.30 | $37.25 |
| Resistance Level | $51.01 | $37.90 |
| Average True Range (ATR) | 2.20 | 0.20 |
| MACD | 0.36 | -0.23 |
| Stochastic Oscillator | 91.44 | 54.92 |
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.
LiveRamp Holdings Inc is a technology company that helps companies build enduring brand and business value by collaborating responsibly with data. A groundbreaking leader in consumer privacy, data ethics, and foundational identity, LiveRamp offers a connected customer view with clarity and context while protecting brand and consumer trust. The Company provides a data collaboration platform, essentially acting as a data collaboration hub where businesses can securely share and manage first-party consumer data with trusted partners while prioritizing data privacy and ethics.